Sandeep Sahay

Dr Sahay is a dedicated pulmonary critical care physician with specialization in pulmonary vascular diseases. He is the divisional director of Clinical & Translational research in the division of pulmonary, critical care & allergy immunology at the Baylor University Medical Center, Dallas, Texas. He also serves as the director of the pulmonary vascular diseases center at the Baylor Univeristy Medical Center, Dallas, Texas. He is well known for his work in the field of pulmonary hypertension. With a passion for improving patient outcomes, he focuses his research on the clinical aspects of PAH, PH ILD and chronic thromboembolic pulmonary hypertension. As a national and international leader in the space, he serves as Principal investigator on multiple phase 2 and 3 clinical trials investigating newer therapies for the treatment of pulmonary arterial hypertension.  Attributed to his sharp knowledge and skill, he is invited to participate in many   scientific steering committees, national leadership roles, guideline panels and in decision making roles with industry and regulatory leadership. He served as a chair of the American college of chest physicians’ Pulmonary Vascular Diseases section 2022-2024. He is currently chairing two guideline/consensus statement task forces with ATS and European Respiratory Society. He also serves executive committee of the American Thoracic Society’s pulmonary circulation assembly and Pulmonary Hypertension association’s scientific leadership committee. He has published numerous scientific papers related to pulmonary hypertension. He is associate editor for pulmonary circulation, JHLT Open and Respiratory Medicine Journals. He serves on end point adjudication committees, DSMB’s for NIH funded studies and multiple clinical trials. He  was awarded the prestigious Outstanding Clinician Award for the year of 2025 by the American Thoracic Society.